Ephedrine as a lead compound for the development of new DPP-IV inhibitors.

about

Ephedrine as a lead compound for the development of new DPP-IV inhibitors.

Item

http://www.wikidata.org/entity/Q46254755

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh

2017年學術文章

@zh-hant

name

Ephedrine as a lead compound for the development of new DPP-IV inhibitors.

@en

Ephedrine as a lead compound for the development of new DPP-IV inhibitors.

@nl

type

Item

label

Ephedrine as a lead compound for the development of new DPP-IV inhibitors.

@en

Ephedrine as a lead compound for the development of new DPP-IV inhibitors.

@nl

prefLabel

Ephedrine as a lead compound for the development of new DPP-IV inhibitors.

@en

Ephedrine as a lead compound for the development of new DPP-IV inhibitors.

@nl

P1476

Ephedrine as a lead compound for the development of new DPP-IV inhibitors

@en

P2093

Adrià Cereto-Massagué

http://www.w3.org/2001/XMLSchema#string

Aleix Gimeno

http://www.w3.org/2001/XMLSchema#string

Andrea Ardid-Ruiz

http://www.w3.org/2001/XMLSchema#string

Cristina Valls

http://www.w3.org/2001/XMLSchema#string

Gerard Pujadas

http://www.w3.org/2001/XMLSchema#string

María José Ojeda-Montes

http://www.w3.org/2001/XMLSchema#string

Sarah Tomás-Hernández

http://www.w3.org/2001/XMLSchema#string

P2860

1,3-disubstituted 4-aminopiperidines as useful tools in the optimization of the 2-aminobenzo[a]quinolizine dipeptidyl peptidase IV inhibitors

Involvement of DPP-IV catalytic residues in enzyme-saxagliptin complex formation

Identification of 3-aminomethyl-1,2-dihydro-4-phenyl-1-isoquinolones: a new class of potent, selective, and orally active non-peptide dipeptidyl peptidase IV inhibitors that form a unique interaction with Lys554

Comparative Analysis of Binding Kinetics and Thermodynamics of Dipeptidyl Peptidase-4 Inhibitors and Their Relationship to Structure

A Review of Natural Stimulant and Non-stimulant Thermogenic Agents

Ephedra in perspective--a current review

Structural requirements for catalysis, expression, and dimerization in the CD26/DPIV gene family

Identification of novel human dipeptidyl peptidase-IV inhibitors of natural origin (part I): virtual screening and activity assays

Identification of novel human dipeptidyl peptidase-IV inhibitors of natural origin (Part II): in silico prediction in antidiabetic extracts

The Principles of Ligand Specificity on beta-2-adrenergic receptor

P304

2129-2146

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.4155/FMC-2017-0080

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Raúl Beltrán-Debón

Santiago Garcia-Vallvé

Miquel Mulero

P577

2017-11-27T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29172693

http://www.w3.org/2001/XMLSchema#string